Menu
Not yet recruiting NCT07606131

Testing a Registry-Based Strategy (ACT+) to Reduce Loss to Follow-Up in Rheumatic Heart Disease Screening in Uganda

No phase Interventional Rheumatic Heart Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: The ACT+ Strategy.
Who it may be relevant to
Registry conditions: Rheumatic Heart Disease. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Uganda
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Developing and Testing a Registry-Enabled Strategy (ACT+) to Reduce Loss to Follow-Up Between Screening and Confirmation of Rheumatic Heart Disease in Uganda

Overview

This study aims to improve follow-up care after positive rheumatic heart disease (RHD) screening in Northern Uganda. It will identify barriers and co-develop an enhanced ACT+ strategy, then evaluate its effectiveness in increasing linkage to confirmatory echocardiography, along with its adoption, acceptability, and feasibility. Secondary outcomes include time to diagnosis, initiation of treatment, and factors influencing implementation.

Interventions

  • Other The ACT+ Strategy
    The Active Community Case Management Tool (ACT) is a cloud-based, dynamic RHD case management tool developed by CCHMC in partnership with global stakeholders, including UHI and the RRCU. ACT provides real-time data on patient status, clinical outcomes, and care processes, supporting both individual patient management (electronic medical record functions) and system-level quality improvement (registry and dashboard functions).

Primary outcome measures

  • Facility-level linkage to confirmation rate [Time frame: 9 months]
Secondary outcome measures (1)
  • Time (days) from positive screen to confirmatory echocardiography [Time frame: 9 months]

Eligibility criteria

Inclusion Criteria: Community Members

  • 18 years of age or older
  • Received a positive ADUNU echocardiographic screening result within the past 24 months OR parent/legal guardian of a minor who received a positive ADUNU echocardiographic screening result within the past 24 months

Inclusion Criteria: Providers

  • Employed at an ADUNU-participating facility or confirmatory echo facilities at the time of study
  • Holds a designated ADUNU role (nurse screener, confirmatory provider, or referral support staff) or is involved in RHD screening, diagnosis or care
  • Ability to provide informed consent in Acholi, Luo, or English

Inclusion Criteria: Regional RHT ACT Nurse Coordinator

  • Employed as a Regional ACT Nurse at the time of study
  • Has familiarity with ADUNU program
  • Ability to provide informed consent in Acholi, Luo, or English

Inclusion Criteria: District Health Office Team Members and District RHD Focal Persons

  • Employed at District Health Office within an ADUNU-participating district
  • Has familiarity with ADUNU program
  • Ability to provide informed consent in Acholi, Luo, or English

Exclusion criteria

  • No formal exclusion criteria beyond inability to provide informed consent. Individuals with significant cognitive or communication impairment precluding interview participation will not be enrolled.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Screening

Study locations

Uganda · 1 center
  • Uganda Heart Institute — Kampala

Identifiers

NCT: NCT07606131 · 2026-0306

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗